
Search
Filter Results
Displaying 691–700 of 1082 results
-
The Legacy Society is a unique group of Foundation Fighting Blindness members who have made a lasting commitment to finding treatments and cures for blinding retinal diseases by making a gift to the Foundation through a will, trust or by beneficiary designation.
The Legacy Society is a way for the Foundation to recognize this profound contribution to retinal research. A gift of any kind to the Foundation is a wonderful act of compassion and generosity.
-
Including the Foundation in your will or trust provides an opportunity to give a larger gift than you may be able to give out of your current assets. By leaving a gift to the Foundation, you can help fight blinding diseases today and for the future.
By leaving a lasting gift, you’re helping the Foundation while retaining the full use of your assets to provide for today’s needs.
-
Simple Ways to Leave Your Legacy
Many people who don’t have the resources to make a significant gift during their lifetime choose to leave a meaningful gift in their will. By leaving a gift to the Foundation, you will provide vital support for the research that will soon find an end to vision loss. You can leave a legacy of sight.
-
Most people are able to make a far more significant gift by including the Foundation in their will or trust or making a gift by beneficiary designation. Often called “legacy gifts”, these types of deferred gifts allow you to continue to be part of ending blindness for many decades to come.
-
Since its founding in 1971, the Foundation Fighting Blindness has been dedicated to funding innovative research to find preventions, treatments, and cures for inherited retinal degenerative diseases that lead to blindness and affect more than 10 million people in the United States.
-
Legacy Society Home page
-
Feb 7, 2020
Genetic Testing for Inherited Retinal Diseases through the Foundation’s Open Access Program
The benefits of genetic testing for IRD patients, how to participate in the Foundation’s Open Access program, and what to expect from the genetic testing process.
-
Feb 6, 2020
My Retina Tracker Program is the highest volume IRD genetic testing program in the U.S.
-
Feb 5, 2020
Al Linde “Keeps on Rolling” with Macular Degeneration
Al Linde has learned to “just roll with it” throughout his life to overcome many challenges.
-
Feb 3, 2020
7th Annual Retinal Cell and Gene Therapy Innovation Summit
Please note that the seventh annual Retinal Cell and Gene Therapy Innovation Summit previously scheduled for Friday, May 1st, 2020 in Baltimore, Maryland has been cancelled.